Herbal Disinfectants in Pharmaceutics: A Comprehensive Review of Curcumin and Neem Oil as Natural Antimicrobial Agents

Abstract

The rising threat of antimicrobial resistance and the growing demand for natural, eco-friendly therapeutic options have renewed scientific and industrial interest in herbal disinfectants as potential alternatives to synthetic antimicrobial agents. Among these, curcumin (Curcuma longa) and neem oil (Azadirachta indica) have emerged as particularly promising candidates owing to their potent antimicrobial properties, favourable safety profiles, and suitability for pharmaceutical formulations. This review explores their antimicrobial mechanisms, pharmaceutical applications, formulation challenges, regulatory frameworks and safety considerations. Recent advances in nanotechnology, bioavailability enhancement strategies, and regulatory compliance are discussed in depth. Furthermore, this review highlights the current trends in personalised herbal medicine, standardisation challenges, and commercial viability of natural antimicrobial formulations. The review concludes that curcumin and neem oil hold substantial potential in pharmaceuticals, especially as sustainable and effective alternatives to conventional antimicrobial agents.

Keywords

Curcumin, Neem Oil, Herbal Disinfectants, Antimicrobial Resistance, Nano emulsion, Pharmaceutical Formulation, Natural Antimicrobials, Bioavailability

Introduction

Antimicrobial Properties and Mechanisms of Action

Curcumin, the primary bioactive component of turmeric (Curcuma longa), exhibits broad-spectrum antimicrobial activity through multiple mechanisms.(1–4) This lipophilic polyphenol (C??H??O?; MW: 368.38 g/mol) has been used in traditional medicine for millennia. Its antimicrobial actions include inhibition of bacterial DNA replication, gene expression modulation, disruption of cell membranes, and impaired motility.(4–6) At the cellular level, curcumin interferes with bacterial cell division by inhibiting the polymerization of FtsZ protofilaments and disrupting GTPase activity in Bacillus subtilis, Escherichia coli, and Staphylococcus aureus.(1,3,7,8) It also induces apoptosis-like responses in bacteria via upregulation of the RecA protein. Moreover, curcumin demonstrates notable antibiofilm activity by blocking quorum sensing systems and removing preformed biofilms.(9) As a natural photosensitizer, curcumin produces cytotoxic reactive oxygen species (ROS) under blue light, making it effective against both planktonic and biofilm forms. Its efficacy is more pronounced against gram-positive bacteria due to the structural differences in the bacterial cell wall. (10–16)

Neem oil, extracted from the seeds of Azadirachta indica, has over thirty-five bioactive compounds, notably azadirachtin, nimbin, nimbolide, gedunin, and various limonoids.(17–19) These constituents synergistically offer broad-spectrum antimicrobial activity against bacteria, fungi and viruses. Neem oil acts by compromising bacterial cell membrane integrity. Nano emulsion formulations of neem oil have shown to cause significant cytoplasmic leakage—up to 85.3%—indicating membrane disruption. Scanning electron microscopy has revealed morphological damage, including disintegration and membrane rupture.(20,21) Nano emulsions with droplet sizes of 30–70 nm penetrates microbial cells more effectively, improving antimicrobial potency. (14,16,17,22–27)

Comparative Antimicrobial Efficacy

Extensive studies on minimum inhibitory concentrations (MICs) for both curcumin and neem oil against diverse pathogenic strains show varying degrees of activity depending on species and bacterial resistance patterns. While curcumin shows higher selectivity toward Gram-positive organisms, neem oil exhibits more generalized broad-spectrum efficacy. (1,2,6,10,11,19,27–32)

Pharmaceutical Formulation Challenges and Solutions

Curcumin suffers from poor water solubility, low oral bioavailability, and rapid degradation. To address these challenges, several strategies have been developed.(2,33–35) Structural modification through chemical derivatives, including salts of potassium, calcium, magnesium, and nitro analogues, improve solubility and pharmacokinetics.(29,34–38) Nano formulation approaches such as encapsulation in liposomes, nanoparticles, micelles, or inclusion complexes like γ-cyclodextrin have significantly enhanced curcumin’s bioavailability. (2,10,39,40)Additionally, combining curcumin with piperine has been shown to increase bioavailability by 150% in rats and up to 2000% in humans. Other promising methods include co-administration with turmeric essential oils and curcuminoid-essential oil complexes. (1,15,32–34,41–45)

Neem oil formulation presents challenges in stability, standardization, and optimized delivery. Its complex composition demands meticulous extraction and standardization.(23,25,26) Nano emulsion technology using ultrasonication and pharmaceutical-grade surfactants like Tween 20 has resulted in stable formulations.(40,46) Controlled-release systems using biodegradable polymers such as alginate and chitosan provide prolonged antimicrobial effects and reduced toxicity. (17,18,24,44,45,47)

Quality Control and Standardization

Curcumin-based formulations are assessed through HPLC, UV-spectrophotometry, and FTIR for chemical analysis, and microbiological assays for antimicrobial and antibiofilm activity.(1,48) Neem oil formulations use GC-MS for phytochemical profiling and dynamic light scattering for nano emulsion characterization. Stability, phase separation, and active content consistency are critical quality indicators. (23,47–51)

Contamination Control and Safety Assessment

Rigorous testing for heavy metals, pesticide residues, and microbial contamination is essential.(52) Tools like ICP-MS, GC-MS, and pharmacopeial microbial limits help ensure safety. Microbiological safety requires regular monitoring of total microbial counts and indicator organisms to meet established thresholds. (53–55)

Safety Profile and Toxicological Considerations

Curcumin shows excellent safety, with no observed toxicity at high doses in animal studies and clinical trials.(36,56) Acute toxicity studies in rats and mice showed no signs of toxicity or mortality at doses up to 5000 mg/kg body weight. The no observed adverse effect level (NOAEL) was 1000 mg/kg per day in 90-day repeated-dose studies.(57) While in vitro studies suggest chromosomal aberrations, in vivo genotoxicity tests such as the micronucleus assay have yielded negative results. Human clinical studies using doses between 207 mg and 5 grams per day have reported no adverse effects.(5,9,58–61)

Neem oil exhibits concentration-dependent toxicity, especially at levels above 1.2 mg/ml. This toxicity is attributed to oxidative stress, reduction of antioxidant enzymes, and DNA damage. The estimated safe dose (ESD) varies with neem preparation type: non-aqueous extracts (0.002–12.5 μg/kg/day), aqueous extracts (0.26–0.3 mg/kg/day), seed oil (2 µL/kg/day), and pure azadirachtin (15 mg/kg/day). Sub-acute exposure may affect reproductive health, and children are particularly vulnerable to neem oil poisoning. (22,27,62)

Regulatory Framework and Guidelines

WHO guidelines for current Good Manufacturing Practices (cGMP) in herbal medicines emphasize quality control, documentation, and traceability from raw material sourcing to final distribution. (63,64)Herbal disinfectants require regulatory approval as antiseptics or disinfectants depending on use. Approval requires demonstration of 99.99% microbial kill within 20–30 seconds, safety for dermal use, stability, and clear labelling of active constituents. Approved forms include solutions, sprays, gels, wipes, and other topical preparations. (65–71)

Current Research Trends and Future Prospects

Recent advances in nanotechnology and drug delivery systems include solid lipid nanoparticles, polymeric carriers, and smart pH-responsive systems. These offer enhanced delivery, targeting, and controlled release.(72,73) Research into synergistic combinations with other natural or synthetic antimicrobials shows promise against resistant strains. Personalized herbal disinfectant development using microbiome and pharmacogenomic data is an emerging frontier, aiming to match therapy to individual microbial profiles and physiological characteristics.(74,75) Emerging technologies such as DNA barcoding, metabolomics, and AI-based quality prediction models improve standardization and traceability. Real-time Internet of Things (IoT) monitoring enhances supply chain integrity. Personalized medicine using patient-specific data may allow tailored herbal disinfectants based on microbial profiles and wound conditions, significantly enhancing therapeutic outcomes and minimizing adverse effects. (51,67,69,70,76–83)(51,67,69,70,76–83)

Challenges in Herbal Drug Development

Standardization of herbal disinfectants is hampered by variability in plant sources, lack of reference standards, and insufficient analytical techniques.(62,84) Regulatory hurdles include limited clinical data, weak pharmacovigilance systems, and complex approval processes. Commercial barriers involve time-consuming development cycles, market promotion challenges, and administrative constraints. (59,68,69,83,85,86)

CONCLUSION

Curcumin and neem oil offer significant potential as natural alternatives to synthetic antimicrobials. Their favourable safety profiles, multi-targeted mechanisms, and eco-friendly nature make them valuable in pharmaceutical development. Addressing formulation, standardization, and regulatory barriers through advanced technologies can pave the way for broader application. For pharmaceutical researchers and students, this field offers an interdisciplinary platform merging traditional wisdom with scientific innovation. As the world faces a mounting crisis of antimicrobial resistance, herbal disinfectants such as curcumin and neem oil represent promising, sustainable, and effective tools for infection control across healthcare, food, and consumer applications.

CONFLICT OF INTEREST: The author declares no conflict of interest.

FUNDING: This research received no external funding.

ETHICAL APPROVAL: Not applicable (review article; no human or animal studies conducted).

REFERENCES

1. Barros CHN, Hiebner DW, Fulaz S, Vitale S, Quinn L, Casey E. Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity. J Nanobiotechnology [Internet]. 2021;19(1):104. Available from: https://doi.org/10.1186/s12951-021-00851-2
2. Abdel-Mageed HM, AbuelEzz NZ, Ali AA, Abdelaziz AE, Nada D, Abdelraouf SM, et al. Newly designed curcumin-loaded hybrid nanoparticles: a multifunctional strategy for combating oxidative stress, inflammation, and infections to accelerate wound healing and tissue regeneration. BMC Biotechnol [Internet]. 2025;25(1):49. Available from: https://doi.org/10.1186/s12896-025-00989-z
3. M. Karajeh A, N. Alkaraki R, Gaber Y. Novel synergistic antibacterial activity of meloxicam-curcumin and diclofenac-curcumin combinations against methicillin-sensitive S. aureus and E. faecium. Beni Suef Univ J Basic Appl Sci [Internet]. 2025;14(1):20. Available from: https://doi.org/10.1186/s43088-025-00606-0
4. Hettiarachchi SS, Perera Y, Dunuweera SP, Dunuweera AN, Rajapakse S, Rajapakse RMG. Comparison of Antibacterial Activity of Nanocurcumin with Bulk Curcumin. ACS Omega [Internet]. 2022 Dec 20;7(50):46494–500. Available from: https://doi.org/10.1021/acsomega.2c05293
5. Bampidis V, Azimonti G, Bastos M de L, Christensen H, Kos Durjava M, Kouba M, et al. Safety and efficacy of turmeric extract, turmeric oil, turmeric oleoresin and turmeric tincture from Curcuma longa L. rhizome when used as sensory additives in feed for all animal species. EFSA Journal. 2020 Jun 1;18(6).
6. Zheng D, Huang C, Huang H, Zhao Y, Khan MRU, Zhao H, et al. Antibacterial Mechanism of Curcumin: A Review. Chem Biodivers [Internet]. 2020 Aug 1;17(8):e2000171. Available from: https://doi.org/10.1002/cbdv.202000171
7. Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr [Internet]. 2020 Mar 25;60(6):887–939. Available from: https://doi.org/10.1080/10408398.2018.1552244
8. Hemaiswarya S, Soudaminikkutty R, Narasumani ML, Doble M. Phenylpropanoids inhibit protofilament formation of Escherichia coli cell division protein FtsZ. J Med Microbiol [Internet]. 2011;60(9):1317–25. Available from: https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.030536-0
9. Shukla A, Parmar P, Rao P, Goswami D, Saraf M. Twin Peaks: Presenting the Antagonistic Molecular Interplay of Curcumin with LasR and LuxR Quorum Sensing Pathways. Curr Microbiol [Internet]. 2020;77(8):1800–10. Available from: https://doi.org/10.1007/s00284-020-01997-2
10. Gayani B, Dilhari A, Wijesinghe GK, Kumarage S, Abayaweera G, Samarakoon SR, et al. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study. Microbiologyopen [Internet]. 2019 May 1;8(5):e00723. Available from: https://doi.org/10.1002/mbo3.723
11. Tyagi Poonam AND Singh MANDKHANDKAANDMK. Bactericidal Activity of Curcumin I Is Associated with Damaging of Bacterial Membrane. PLoS One [Internet]. 2015 Aug;10(3):1–15. Available from: https://doi.org/10.1371/journal.pone.0121313
12. Tian WW, Liu L, Chen P, Yu DM, Li QM, Hua H, et al. Curcuma Longa (turmeric): from traditional applications to modern plant medicine research hotspots. Chin Med [Internet]. 2025;20(1):76. Available from: https://doi.org/10.1186/s13020-025-01115-z
13. Bharat Aggarwal CB, Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Kishor Roy N, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. 2016; Available from: http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc
14. Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Mol Nutr Food Res [Internet]. 2013 Sep 1;57(9):1510–28. Available from: https://doi.org/10.1002/mnfr.201100741
15. Yallapu MM, Nagesh PKB, Jaggi M, Chauhan SC. Therapeutic Applications of Curcumin Nanoformulations. AAPS J [Internet]. 2015;17(6):1341–56. Available from: https://doi.org/10.1208/s12248-015-9811-z
16. Nazari M, Shokoohizadeh L, Taheri M. Natural products in the treatment of diabetic foot infection. Eur J Med Res [Internet]. 2025;30(1):8. Available from: https://doi.org/10.1186/s40001-024-02255-y
17. Rinaldi F, Hanieh PN, Longhi C, Carradori S, Secci D, Zengin G, et al. Neem oil nanoemulsions: characterisation and antioxidant activity. J Enzyme Inhib Med Chem [Internet]. 2017 Jan 1;32(1):1265–73. Available from: https://doi.org/10.1080/14756366.2017.1378190
18. Anjali CH, Sharma Y, Mukherjee A, Chandrasekaran N. Neem oil (Azadirachta indica) nanoemulsion—a potent larvicidal agent against Culex quinquefasciatus. Pest Manag Sci [Internet]. 2012;68(2):158–63. Available from: https://scijournals.onlinelibrary.wiley.com/doi/abs/10.1002/ps.2233
19. Koul O, Isman MB, Ketkar CM. Properties and uses of neem, Azadirachta indica. Canadian Journal of Botany [Internet]. 1990;68(1):1–11. Available from: https://doi.org/10.1139/b90-001
20. Altayb HN, Yassin NF, Hosawi S, Kazmi I. In-vitro and in-silico antibacterial activity of Azadirachta indica (Neem), methanolic extract, and identification of Beta.d-Mannofuranoside as a promising antibacterial agent. BMC Plant Biol [Internet]. 2022;22(1):262. Available from: https://doi.org/10.1186/s12870-022-03650-5
21. Killi N, Pawar AT, Gundloori RVN. Polyesteramide of Neem Oil and Its Blends as an Active Nanomaterial for Tissue Regeneration. ACS Appl Bio Mater [Internet]. 2019 Aug 19;2(8):3341–51. Available from: https://doi.org/10.1021/acsabm.9b00354
22. Wang  C., Cao  M., Shi  D-X., Yin  Z-Q., Jia  R-Y., Wang  K-Y., et al. A 90-day subchronic toxicity study of neem oil, a Azadirachtaindica oil, in mice. Hum Exp Toxicol [Internet]. 2013 Feb 25;32(9):904–13. Available from: https://doi.org/10.1177/0960327113475677
23. Ramadhany P, Witono JRB, Rosaria R. Neem-based oil-in-water (O/W) emulsion as a biopesticide. IOP Conf Ser Mater Sci Eng [Internet]. 2021 Feb;1053(1):12047. Available from: https://dx.doi.org/10.1088/1757-899X/1053/1/012047
24. Gossé B, Amissa AA, Anoh Adjé F, Bobélé Niamké F, Ollivier D, Ito Y. Analysis of Components of Neem (Azadirachta indica) Oil by Diverse Chromatographic Techniques. J Liq Chromatogr Relat Technol [Internet]. 2005 Aug 1;28(14):2225–33. Available from: https://doi.org/10.1081/JLC-200064164
25. Saleem S, Muhammad G, Hussain MA, Bukhari SNA. A comprehensive review of phytochemical profile, bioactives for pharmaceuticals, and pharmacological attributes of Azadirachta indica. Phytotherapy Research [Internet]. 2018 Jul 1;32(7):1241–72. Available from: https://doi.org/10.1002/ptr.6076
26. Ponnusamy S, Haldar S, Mulani F, Zinjarde S, Thulasiram H, RaviKumar A. Gedunin and Azadiradione: Human Pancreatic Alpha-Amylase Inhibiting Limonoids from Neem (Azadirachta indica) as Anti-Diabetic Agents. PLoS One [Internet]. 2015 Oct 15;10(10):e0140113-. Available from: https://doi.org/10.1371/journal.pone.0140113
27. Sati A, Ranade TN, Mali SN, Ahmad Yasin HK, Pratap A. Silver Nanoparticles (AgNPs): Comprehensive Insights into Bio/Synthesis, Key Influencing Factors, Multifaceted Applications, and Toxicity?A 2024 Update. ACS Omega [Internet]. 2025 Mar 4;10(8):7549–82. Available from: https://doi.org/10.1021/acsomega.4c11045
28. Zhang YQ, Xu J, Yin ZQ, Jia RY, Lu Y, Yang F, et al. Isolation and identification of the antibacterial active compound from petroleum ether extract of neem oil. Fitoterapia [Internet]. 2010;81(7):747–50. Available from: https://www.sciencedirect.com/science/article/pii/S0367326X10000742
29. Kunnumakkara AB, Hegde M, Parama D, Girisa S, Kumar A, Daimary UD, et al. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials. ACS Pharmacol Transl Sci [Internet]. 2023 Apr 14;6(4):447–518. Available from: https://doi.org/10.1021/acsptsci.2c00012
30. Noor H, Ikram A, Rathinavel T, Kumarasamy S, Nasir Iqbal M, Bashir Z. Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 – a computational modeling. J Biomol Struct Dyn [Internet]. 2022 Jul 21;40(13):5769–84. Available from: https://doi.org/10.1080/07391102.2021.1873190
31. Debnath S, Das M, Mondal S, Sarkar BK, Babu G. Neem (Azadirachta indica A. Juss): a multifaceted tree & an elixir in the traditional system of Indian medicine. Discover Plants [Internet]. 2025;2(1):156. Available from: https://doi.org/10.1007/s44372-025-00196-2
32. Kim M, Shin M, Zhao Y, Ghosh M, Son YO. Transformative Impact of Nanocarrier-Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons. Small Science [Internet]. 2024 Nov 1;4(11):2400280. Available from: https://doi.org/10.1002/smsc.202400280
33. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of Curcumin: Problems and Promises. Mol Pharm [Internet]. 2007 Dec 1;4(6):807–18. Available from: https://doi.org/10.1021/mp700113r
34. Sanidad KZ, Sukamtoh E, Xiao H, McClements DJ, Zhang G. Curcumin: Recent Advances in the Development of Strategies to Improve Oral Bioavailability. Annu Rev Food Sci Technol [Internet]. 2019;10(Volume 10, 2019):597–617. Available from: https://www.annualreviews.org/content/journals/10.1146/annurev-food-032818-121738
35. Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin Drug Deliv [Internet]. 2012 Nov 1;9(11):1347–64. Available from: https://doi.org/10.1517/17425247.2012.724676
36. Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far? ACS Omega [Internet]. 2023 Mar 28;8(12):10713–46. Available from: https://doi.org/10.1021/acsomega.2c07326
37. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal [Internet]. 1997;15(12):1867–76. Available from: https://www.sciencedirect.com/science/article/pii/S0731708596020249
38. Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J Integr Med [Internet]. 2018;16(6):367–74. Available from: https://www.sciencedirect.com/science/article/pii/S2095496418300773
39. Sun M, Su X, Ding B, He X, Liu X, Yu A, et al. Advances in Nanotechnology-Based Delivery Systems for Curcumin. Nanomedicine [Internet]. 2012 Jul 1;7(7):1085–100. Available from: https://doi.org/10.2217/nnm.12.80
40. Mirza AZ, Siddiqui FA. Nanomedicine and drug delivery: a mini review. Int Nano Lett [Internet]. 2014;4(1):94. Available from: https://doi.org/10.1007/s40089-014-0094-7
41. Schoeman C, van Niekerk S, Liebenberg W, Hamman J. Cyclodextrin inclusion complex and amorphous solid dispersions as formulation approaches for enhancement of curcumin’s solubility and nasal epithelial membrane permeation. Futur J Pharm Sci [Internet]. 2024;10(1):85. Available from: https://doi.org/10.1186/s43094-024-00656-8
42. Liu Z, Smart JD, Pannala AS. Recent developments in formulation design for improving oral bioavailability of curcumin: A review. J Drug Deliv Sci Technol [Internet]. 2020;60:102082. Available from: https://www.sciencedirect.com/science/article/pii/S177322472031371X
43. Powell LC, Sowedan A, Khan S, Wright CJ, Hawkins K, Onsøyen E, et al. The effect of alginate oligosaccharides on the mechanical properties of Gram-negative biofilms. Biofouling [Internet]. 2013 Apr 1;29(4):413–21. Available from: https://doi.org/10.1080/08927014.2013.777954
44. Yang CS, Sang S, Lambert JD, Lee MJ. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res [Internet]. 2008 Jun 1;52(S1):S139–51. Available from: https://doi.org/10.1002/mnfr.200700234
45. Panda SR, Meher A, Prusty G, Behera S, Prasad BR. Antibacterial properties and therapeutic potential of few medicinal plants: current insights and challenges. Discover Plants. 2025 Jan 28;2(1).
46. Namratha Vinaya K, Mary John A, Mangsatabam M, Anna Philip M. Ultrasound-assisted synthesis and characterization of sesame oil based nanoemulsion. IOP Conf Ser Mater Sci Eng [Internet]. 2021;1114(1):012085. Available from: https://dx.doi.org/10.1088/1757-899X/1114/1/012085
47. Ismail T, Keratum A, El-Hetawy L. Formulation of abamectin and plant oil-based nanoemulsions with efficacy against the two-spotted spider mite Tetranychus urticae (Acari: Tetranychidae) under laboratory and field conditions. Appl Biol Chem [Internet]. 2022;65(1):61. Available from: https://doi.org/10.1186/s13765-022-00731-9
48. Maghraby YR, Ibrahim AH, El-Shabasy RM, Azzazy HMES. Overview of Nanocosmetics with Emphasis on those Incorporating Natural Extracts. ACS Omega [Internet]. 2024 Aug 27;9(34):36001–22. Available from: https://doi.org/10.1021/acsomega.4c00062
49. Brinckmann J, Marles R, Schiff P, Oketch-Rabah H, Tirumalai G, Giancaspro G, et al. QUALITY STANDARDS FOR BOTANICALS THE LEGACY OF USP’S 200 YEARS OF CONTRIBUTIONS. HerbalGram. 2020;(126).
50. Sarma N, Upton R, Rose U, Guo D an, Marles R, Khan I, et al. Pharmacopeial Standards for the Quality Control of Botanical Dietary Supplements in the United States. J Diet Suppl [Internet]. 2023 May 4;20(3):485–504. Available from: https://doi.org/10.1080/19390211.2021.1990171
51. Hora PI, Pati SG, McNamara PJ, Arnold WA. Increased Use of Quaternary Ammonium Compounds during the SARS-CoV-2 Pandemic and Beyond: Consideration of Environmental Implications. Environ Sci Technol Lett [Internet]. 2020 Sep 8;7(9):622–31. Available from: https://doi.org/10.1021/acs.estlett.0c00437
52. Mansour SA. Residual Pesticides and Heavy Metals Analysis in Food. In: Analysis of Food Toxins and Toxicants [Internet]. 2017. p. 537–70. Available from: https://doi.org/10.1002/9781118992685.ch18
53. Pop OL, Ciont (Nagy) C, Gabbianelli R, Coldea TE, Pop CR, Mudura E, et al. Deciphering contaminants and toxins in fermented food for enhanced human health safeguarding. Compr Rev Food Sci Food Saf [Internet]. 2024 Sep 1;23(5):e13428. Available from: https://doi.org/10.1111/1541-4337.13428
54. Hara TO, Singh B. Electrochemical Biosensors for Detection of Pesticides and Heavy Metal Toxicants in Water: Recent Trends and Progress. ACS ES&T Water [Internet]. 2021 Mar 12;1(3):462–78. Available from: https://doi.org/10.1021/acsestwater.0c00125
55. Zeitoun H, Kassem M, Raafat D, AbouShlieb H, Fanaki N. Microbiological testing of pharmaceuticals and cosmetics in Egypt. BMC Microbiol [Internet]. 2015;15(1):275. Available from: https://doi.org/10.1186/s12866-015-0609-z
56. Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The Essential Medicinal Chemistry of Curcumin. J Med Chem [Internet]. 2017 Mar 9;60(5):1620–37. Available from: https://doi.org/10.1021/acs.jmedchem.6b00975
57. Tiwari R, Siddiqui MH, Mahmood T, Farooqui A, Bagga P, Ahsan F, et al. An exploratory analysis on the toxicity & safety profile of Polyherbal combination of curcumin, quercetin and rutin. Clinical Phytoscience [Internet]. 2020;6(1):82. Available from: https://doi.org/10.1186/s40816-020-00228-2
58. Badmaev  Vladimir, Vik  Hogne, Stohs  Sidney J, Galluzzo  Frank. Safety and toxicological evaluation of NXT15906F6 (TamaFlex®): A food-derived botanical composition containing standardized extracts of Tamarindus indica seeds and Curcuma longa rhizomes. Toxicology Research and Application [Internet]. 2018 Jan 1;2:2397847317749240. Available from: https://doi.org/10.1177/2397847317749240
59. Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytotherapy Research [Internet]. 2018 Jun 1;32(6):985–95. Available from: https://doi.org/10.1002/ptr.6054
60. Wei XC, Cao B, Luo CH, Huang HZ, Tan P, Xu XR, et al. Recent advances of novel technologies for quality consistency assessment of natural herbal medicines and preparations. Chin Med [Internet]. 2020;15(1):56. Available from: https://doi.org/10.1186/s13020-020-00335-9
61. (FEEDAP) EP on A and P or S used in AF, Bampidis V, Azimonti G, Bastos M de L, Christensen H, Kos Durjava M, et al. Safety and efficacy of turmeric extract, turmeric oil, turmeric oleoresin and turmeric tincture from Curcuma longa L. rhizome when used as sensory additives in feed for all animal species. EFSA Journal [Internet]. 2020 Jun 1;18(6):e06146. Available from: https://doi.org/10.2903/j.efsa.2020.6146
62. Balekundri A, Mannur V. Quality control of the traditional herbs and herbal products: a review. Futur J Pharm Sci [Internet]. 2020;6(1):67. Available from: https://doi.org/10.1186/s43094-020-00091-5
63. Mukherjee PK. Problems and Prospects for Good Manufacturing Practice for Herbal Drugs in Indian Systems of Medicine. Drug information journal?: DIJ / Drug Information Association [Internet]. 2002;36(3):635–44. Available from: https://doi.org/10.1177/009286150203600318
64. Organization WH. Good Manufacturing Practices: supplementary guidelines for the manufacture of herbal medicinal products. WHO Expert Committee on “Specifications for Pharmaceutical Preparations”, 34th report, WHO, Geneva, Switzerland, Annex. 1996;8:134–9.
65. Günter K, Axel K. Epidemiologic Background of Hand Hygiene and Evaluation of the Most Important Agents for Scrubs and Rubs. Clin Microbiol Rev [Internet]. 2004 Oct 1;17(4):863–93. Available from: https://doi.org/10.1128/cmr.17.4.863-893.2004
66. Arnold WA, Blum A, Branyan J, Bruton TA, Carignan CC, Cortopassi G, et al. Quaternary Ammonium Compounds: A Chemical Class of Emerging Concern. Environ Sci Technol [Internet]. 2023 May 23;57(20):7645–65. Available from: https://doi.org/10.1021/acs.est.2c08244
67. Balkrishna A, Singh K, Haldar S, Varshney A. Germi-X herbal-based spray disinfects smartphone surfaces: implication on fomite-mediated infection spread. AMB Express [Internet]. 2022;12(1):30. Available from: https://doi.org/10.1186/s13568-022-01369-y
68. De Smet PAGM. Should herbal medicine-like products be licensed as medicines. Vol. 310, BMJ. British Medical Journal Publishing Group; 1995. p. 1023–4.
69. Organization WH. Regulatory situation of herbal medicines: a worldwide review. 1998;
70. Anonymous. GMP for Ayurveda, Siddha, Unani (ASU) medicines. IDMA Bulletin. 2000;31(27):612–20.
71. Organization WH. Good Manufacturing Practices: supplementary guidelines for the manufacture of herbal medicinal products. WHO Expert Committee on “Specifications for Pharmaceutical Preparations”, 34th report, WHO, Geneva, Switzerland, Annex. 1996;8:134–9.
72. Shi Y, Li X, Li Z, Sun J, Gao T, Wei G, et al. Nano-formulations in disease therapy: designs, advances, challenges, and future directions. J Nanobiotechnology [Internet]. 2025;23(1):396. Available from: https://doi.org/10.1186/s12951-025-03442-7
73. Hussein HA, Khaphi FL, Sivaramakrishnan R, Poornima S, Abdullah MA. Recent developments in sustained-release and targeted drug delivery applications of solid lipid nanoparticles. J Microencapsul [Internet]. 2025 Jul 4;42(5):472–502. Available from: https://doi.org/10.1080/02652048.2025.2495290
74. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres M del P, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology [Internet]. 2018;16(1):71. Available from: https://doi.org/10.1186/s12951-018-0392-8
75. Soulaimani  Bouchra. Comprehensive Review of the Combined Antimicrobial Activity of Essential Oil Mixtures and Synergism with Conventional Antimicrobials. Nat Prod Commun [Internet]. 2025 Mar 1;20(3):1934578X251328241. Available from: https://doi.org/10.1177/1934578X251328241
76. Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid Nanoparticles?From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano [Internet]. 2021 Nov 23;15(11):16982–7015. Available from: https://doi.org/10.1021/acsnano.1c04996
77. Gajbhiye KR, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Mol Cancer [Internet]. 2023;22(1):160. Available from: https://doi.org/10.1186/s12943-023-01849-0
78. Haripriyaa M, Suthindhiran K. Pharmacokinetics of nanoparticles: current knowledge, future directions and its implications in drug delivery. Futur J Pharm Sci [Internet]. 2023;9(1):113. Available from: https://doi.org/10.1186/s43094-023-00569-y
79. Anwar DM, Hedeya HY, Ghozlan SH, Ewas BM, Khattab SN. Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: application and recent advances in targeted cancer treatment‏. Beni Suef Univ J Basic Appl Sci [Internet]. 2024;13(1):106. Available from: https://doi.org/10.1186/s43088-024-00566-x
80. Akhtar W, Hamza MI, Qayyum S, Khan MA, Mukhtar N, Kamal A, et al. Phyto-synthesis, characterization of silver nanoparticles from mint leaf extract and its evaluation in antimicrobial and pharmacological applications. BMC Plant Biol [Internet]. 2025;25(1):1072. Available from: https://doi.org/10.1186/s12870-025-07043-2
81. Seyhan AA, Carini C. Are innovation and new technologies in precision medicine paving a new era in patients centric care? J Transl Med [Internet]. 2019;17(1):114. Available from: https://doi.org/10.1186/s12967-019-1864-9
82. Cheng Z, Huang H, Yin M, Liu H. Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects. Exp Hematol Oncol [Internet]. 2025;14(1):11. Available from: https://doi.org/10.1186/s40164-025-00602-1
83. Ai S, Li Y, Zheng H, Zhang M, Tao J, Liu W, et al. Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023. J Nanobiotechnology [Internet]. 2024;22(1):140. Available from: https://doi.org/10.1186/s12951-024-02426-3
84. Wei XC, Cao B, Luo CH, Huang HZ, Tan P, Xu XR, et al. Recent advances of novel technologies for quality consistency assessment of natural herbal medicines and preparations. Chin Med [Internet]. 2020;15(1):56. Available from: https://doi.org/10.1186/s13020-020-00335-9
85. 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018. Drug Saf [Internet]. 2018;41(11):1103–273. Available from: https://doi.org/10.1007/s40264-018-0719-2
86. Adeeyo AO, Edokpayi JN, Alabi MA, Msagati TAM, Odiyo JO. Plant active products and emerging interventions in water potabilisation: disinfection and multi-drug resistant pathogen treatment. Clinical Phytoscience [Internet]. 2021;7(1):31. Available from: https://doi.org/10.1186/s40816-021-00258-4